We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
+3.82%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$5.38M
Cap. Flow
-$5.42M
Cap. Flow %
-4.55%
Top 10 Hldgs %
36.72%
Holding
80
New
8
Increased
27
Reduced
7
Closed
11

Top Buys

1
INCY icon
Incyte
INCY
+$1.8M
2
WBA
Walgreens Boots Alliance
WBA
+$1.67M
3
BIDU icon
Baidu
BIDU
+$1.6M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.53M
5
BABA icon
Alibaba
BABA
+$1.47M

Top Sells

1
IMGN
Immunogen Inc
IMGN
+$14.8M
2
NHC icon
National Healthcare
NHC
+$2.77M
3
TAST
Carrols Restaurant Group, Inc.
TAST
+$2.76M
4
FCX icon
Freeport-McMoran
FCX
+$2.13M
5
BGC icon
BGC Group
BGC
+$1.85M

Sector Composition

1 Healthcare 42.71%
2 Industrials 9.53%
3 Technology 8.54%
4 Materials 8.18%
5 Consumer Staples 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TRC icon
51
Tejon Ranch
TRC
$497M
$693K 0.58%
45,000
+5,000
+13% +$80.9K
FEMY icon
52
Femasys
FEMY
$8.91M
$620K 0.52%
20,000
-2,500
-11% -$65.6K
CMPX icon
53
Compass Therapeutics
CMPX
$378M
$614K 0.52%
310,000
+185,000
+148% +$320K
LTRN icon
54
Lantern Pharma
LTRN
$38.9M
$572K 0.48%
65,000
-15,000
-19% -$80.2K
ELTX icon
55
Elicio Therapeutics
ELTX
$84.3M
$570K 0.48%
75,000
+25,000
+50% +$125K
VRNA
56
DELISTED
Verona Pharma
VRNA
$563K 0.47%
+35,000
New +$605K
THFF icon
57
First Financial Corp
THFF
$910M
$537K 0.45%
+14,000
New +$543K
VTOL icon
58
Bristow Group
VTOL
$1.31B
$418K 0.35%
+15,377
New +$410K
GANX icon
59
Gain Therapeutics
GANX
$72.1M
$339K 0.29%
90,000
– –
ASRT
60
DELISTED
Assertio
ASRT
$331K 0.28%
23,000
– –
ELDN icon
61
Eledon Pharmaceuticals
ELDN
$310M
$330K 0.28%
160,000
+20,000
+14% +$35.7K
KRON
62
DELISTED
Kronos Bio
KRON
$325K 0.27%
250,000
– –
CGTX icon
63
Cognition Therapeutics
CGTX
$87.6M
$319K 0.27%
+175,000
New +$361K
CADE
64
DELISTED
Cadence Bank
CADE
$290K 0.24%
10,000
– –
BCDA icon
65
BioCardia
BCDA
$12.7M
$285K 0.24%
46,667
– –
EDSA icon
66
Edesa Biotech
EDSA
$64.5M
$260K 0.22%
62,000
– –
SMSI icon
67
Smith Micro Software
SMSI
$14.3M
$207K 0.17%
15,000
– –
RNAC icon
68
Cartesian Therapeutics
RNAC
$252M
$199K 0.17%
10,183
-13,150
-56% -$279K
PVLA
69
Palvella Therapeutics
PVLA
$2.22B
$105K 0.09%
7,188
-2,187
-23% -$30.5K
APA icon
70
APA Corp
APA
$12.3B
– –
-25,000
Closed -$897K
FCX icon
71
Freeport-McMoran
FCX
$84.9B
– –
-50,000
Closed -$2.13M
FIS icon
72
Fidelity National Information Services
FIS
$21.7B
– –
-17,500
Closed -$1.05M
FNF icon
73
Fidelity National Financial
FNF
$14B
– –
-25,000
Closed -$1.28M
NHC icon
74
National Healthcare
NHC
$3.57B
– –
-30,000
Closed -$2.77M
VTLE
75
DELISTED
Vital Energy
VTLE
– –
-15,000
Closed -$682K
1 2
3
4

Similar funds

AA
Ahara Advisors Jersey City, New Jersey $120M AUM
CC
Commons Capital Needham, Massachusetts $120M AUM 31.45% 1-Year Est. Return
DG
Dala Group Hoffman Estates, Illinois $120M AUM
ACM
AIHC Capital Management Central $120M AUM
WAG
Windsor Advisory Group Columbus, Ohio $120M AUM 4.29% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
IW
Integrated Wealthcare Durham, North Carolina $120M AUM
BCWM
Ball & Co Wealth Management Franklin, Tennessee $120M AUM 21.28% 1-Year Est. Return

CM Management's Q1 2024 Portfolio in Review

As of Q1 2024, CM Management held 80 positions worth $119M, down 4.3% from $124M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

CM Management withdrew a net $5.42M in Q1 2024, closing 11 positions and reducing 7 holdings. Its most notable exit was Immunogen Inc, an estimated $14.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 44% a quarter earlier, followed by Industrials and Technology.

Against the trend, CM Management opened a new position in Incyte worth $1.71M.

  • CM Management's largest Q1 2024 buy was Incyte: 30,000 shares worth $1.71M.
  • CM Management added most to Walgreens Boots Alliance in Q1 2024, an estimated $1.67M increase.
  • CM Management's biggest Q1 2024 reduction was BGC Group, cutting an estimated $1.85M.
  • CM Management fully exited Immunogen Inc in Q1 2024, selling an estimated $14.8M.
  • CM Management's ten largest holdings make up 37% of its $119M portfolio in Q1 2024.
  • CM Management opened 8 new positions and closed 11 in Q1 2024.
  • CM Management's portfolio value fell 4.3% quarter-over-quarter to $119M.

Based on CM Management's 13F filing for Q1 2024, filed 14 May 2024.